| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 914 | 2022 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 579 | 2022 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 270 | 2021 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 131 | 2022 |
| Sustained T cell immunity, protection and boosting using extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, D Skelly, W Dejnirattisai, S Adele, ... | 21 | 2021 |
| Rapid escape of new SARS-CoV-2 Omicron variants from BA. 2-directed antibody responses A Dijokaite-Guraliuc, R Das, D Zhou, HM Ginn, C Liu, HME Duyvesteyn, ... Cell reports 42 (4), 2023 | 20 | 2023 |
| Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... Med 4 (3), 191-215. e9, 2023 | 18 | 2023 |
| Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant SM Murray, M Barbanti, C Campbell, A Brown, L Chen, J Dhanapal, ... British Journal of Haematology 198 (4), 668-679, 2022 | 16 | 2022 |
| Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination SA Johnson, E Phillips, S Adele, S Longet, T Malone, C Mason, L Stafford, ... Clinical and Experimental Immunology 212 (3), 249-261, 2023 | 13 | 2023 |
| Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers Clinical and Experimental Immunology 209 (1), 90-98, 2022 | 9 | 2022 |
| Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... MedRxiv, 2022.06. 06.22275865, 2022 | 8 | 2022 |
| Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients SM Murray, E Pose, M Wittner, MC Londoño, G Schaub, J Cook, ... Journal of Hepatology 80 (1), 109-123, 2024 | 2 | 2024 |
| Using algorithms in critical care outreach: UCLH Trust Patient Emergency Response Team (PERT) algorithm for heart rate> 125 J Hartin, J Cook, E Phillips, M Singer, A Webb, SK Adam Care of the Critically Ill 18 (5), 158-159, 2002 | 2 | 2002 |
| 67 Bridging the gap: Linking early post-vaccine events to reactogenicity and later immune responses after viral-vectored and mRNA-based SARS-CoV-2 vaccines A Amini, L Garner, S Adele, E Phillips, T Malone, W Dejnirattisai, D Skelly, ... Clinical Infection in Practice 20, 100269, 2023 | | 2023 |
| P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY YJ Lim, V Ward, L Farrell, D Naisbitt, A Brown, E Phillips, P Thomson, ... HemaSphere 7 (Suppl), 2023 | | 2023 |
| Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination (preprint) SA Johnson, E Phillips, S Adele, SA Longet, T Malone, C Mason, ... | | 2022 |
